Label: NYX PROFESSIONAL MAKEUP BARE WITH ME DAILY MOISTURIZING PRIMER WITH CANNABIS SATIVA SEED OIL SPF 30- avobenzone, homosalate, octisalate and octocrylene cream
- NDC Code(s): 49967-217-01
- Packager: L'Oreal USA Products Inc
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated January 16, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredients
- Purpose
- Uses
- Warnings
- Do not use
- When using this product
- Stop use and ask a doctor if
- Keep out of reach of children.
-
Directions
For sunscreen use:
● apply liberally 15 minutes before sun exposure
● reapply at least every 2 hours
● use a water resistant sunscreen if swimming or sweating
● Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
● limit time in the sun, especially from 10 a.m. – 2 p.m.
● wear long-sleeved shirts, pants, hats, and sunglasses
● children under 6 months of age: Ask a doctor
- Other information
-
Inactive ingredients
water, glycerin, silica, dimethicone, PEG-100 stearate, glyceryl stearate, cannabis sativa seed oil, stearic acid, phenoxyethanol, palmitic acid, ammonium polyacryloyldimethyl taurate, steareth-100, phenylethyl resorcinol, caprylyl salicylic acid, caprylyl glycol, xanthan gum, dimethicone/vinyl dimethicone crosspolymer, disodium EDTA, fragrance, sodium hyaluronate, tocopherol, dipropylene glycol, ascorbyl glucoside, myristic acid, sodium palmitoyl proline, sodium hydroxide, centella asiatica extract, butylene glycol, linalool, geraniol, limonene, nymphaea alba flower extract
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
NYX PROFESSIONAL MAKEUP BARE WITH ME DAILY MOISTURIZING PRIMER WITH CANNABIS SATIVA SEED OIL SPF 30
avobenzone, homosalate, octisalate and octocrylene creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:49967-217 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE 30 mg in 1 mL HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE 50 mg in 1 mL OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE 50 mg in 1 mL OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE 70 mg in 1 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) GLYCERIN (UNII: PDC6A3C0OX) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) DIMETHICONE (UNII: 92RU3N3Y1O) PEG-100 STEARATE (UNII: YD01N1999R) GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4) CANNABIS SATIVA SEED OIL (UNII: 69VJ1LPN1S) STEARIC ACID (UNII: 4ELV7Z65AP) PHENOXYETHANOL (UNII: HIE492ZZ3T) PALMITIC ACID (UNII: 2V16EO95H1) AMMONIUM POLYACRYLOYLDIMETHYL TAURATE (UNII: F01RIY4371) STEARETH-100 (UNII: 4OH5W9UM87) PHENYLETHYL RESORCINOL (UNII: G37UFG162O) CAPRYLOYL SALICYLIC ACID (UNII: 5F7PJF6AA4) CAPRYLYL GLYCOL (UNII: 00YIU5438U) XANTHAN GUM (UNII: TTV12P4NEE) DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5) EDETATE DISODIUM (UNII: 7FLD91C86K) HYALURONATE SODIUM (UNII: YSE9PPT4TH) TOCOPHEROL (UNII: R0ZB2556P8) DIPROPYLENE GLYCOL (UNII: E107L85C40) ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW) MYRISTIC ACID (UNII: 0I3V7S25AW) SODIUM PALMITOYL PROLINE (UNII: 64L053FRFO) SODIUM HYDROXIDE (UNII: 55X04QC32I) CENTELLA ASIATICA (UNII: 7M867G6T1U) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) LINALOOL, (+)- (UNII: F4VNO44C09) GERANIOL (UNII: L837108USY) LIMONENE, (+)- (UNII: GFD7C86Q1W) NYMPHAEA ALBA FLOWER (UNII: 40KQ7Q535O) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:49967-217-01 1 in 1 CARTON 04/01/2020 1 75 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M020 04/01/2020 Labeler - L'Oreal USA Products Inc (002136794) Establishment Name Address ID/FEI Business Operations L'Oreal USA Products Inc 624244349 manufacture(49967-217)